LAB — Labiana Health SA Cashflow Statement
0.000.00%
Last trade - 00:00- €21.01m
- €22.50m
- €66.26m
- 87
- 66
- 95
- 98
Annual cashflow statement for Labiana Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.541 | -2.12 | -7.84 | -5.28 | -0.03 |
| Depreciation | |||||
| Non-Cash Items | 2.01 | 2.44 | 4.97 | 3.28 | 4.78 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.65 | -1.42 | 2.71 | -4.91 | -1.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.79 | 3.91 | 4.68 | -1.83 | 7.19 |
| Capital Expenditures | -6.73 | -4.77 | -5.45 | -2.85 | -3.05 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.537 | -2.46 | 2.51 | 0.817 | -0.938 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Cash from Investing Activities | -7.26 | -7.23 | -2.95 | -2.03 | -3.99 |
| Financing Cash Flow Items | — | -1.13 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.9 | 5.06 | -2.5 | 4.3 | 0.572 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.572 | 1.74 | -0.762 | 0.439 | 3.78 |